Updated:
Edge BioSystems
Edge BioSystems is a biosystems firm based in Gaithersburg, Maryland, focused on applied biology and healthcare technology.
Edge BioSystems
Edge BioSystems is based in Gaithersburg, Maryland, a hub for biotech and life science firms in the Washington, D.C. metro area. The company's exact founding year and principal operators are not publicly documented, but its focus on biosystems suggests a venture-stage or family-office-backed entity in biological product development. The wealth origin behind the firm remains undisclosed. Edge BioSystems likely targets the healthcare services and agricultural technology sectors, developing biological platforms that may include diagnostics, therapeutics, or crop-science products. The company's Gaithersburg location places it near the National Institutes of Health and other federal research institutions, which could provide talent and partnership opportunities. Without specific disclosed portfolio companies or deals, the firm's asset-class mix and investment-stage preferences are inferred from its stated focus on biosystems. The firm's team size and adjacent vehicles such as philanthropic foundations or operating companies are not publicly documented. No recent operational events (within the last 24 months) could be verified through available sources. The company's website at edgebio.com does not provide further details on professionals, offices, or strategic activities. Edge BioSystems' structural differentiator may lie in its specialized focus on applied biosystems, a space that bridges fundamental biology and commercial deployment. However, the limited available information prevents a deeper assessment of its governance, succession, or operating-company relationships.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Gaithersburg
Corporate office
Gaithersburg, MD, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Edge BioSystems?
The principals or investment decision-makers at Edge BioSystems are not publicly disclosed. The firm does not list a management team or board on its website or in public records. Allocators seeking this information should contact the firm directly.
What sectors does Edge BioSystems focus on?
Based on its name, location, and implied domain, Edge BioSystems focuses on the healthcare services and agricultural technology sectors. The company develops biological systems, which may include diagnostics, therapeutics, or crop-science applications.
How is Edge BioSystems structured?
The firm's organizational structure is not publicly documented. It may operate as a private company backed by a family office or a venture-stage entity. No information is available on whether it uses fund vehicles, direct investments, or other structures.
Where does the underlying wealth for Edge BioSystems come from?
The source of wealth behind Edge BioSystems is not publicly disclosed. The firm does not reveal its ownership or backers in available sources.
What is Edge BioSystems' known posture on co-investments?
There is no public information about Edge BioSystems' involvement in co-investments or partnerships with external investors. The firm does not disclose its investment strategy or deal structures.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: